OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

PHILLIPS 66 DL-,01/  US7185461040  /

Lang & Schwarz
7/27/2024  1:04:17 PM Chg. 0.00 Volume Bid1:04:17 PM Ask1:04:17 PM Market Capitalization Dividend Y. P/E Ratio
129.96EUR 0.00% -
Turnover: -		 129.96Bid Size: - 132.06Ask Size: - 55.53 bill.EUR - -
Newsfile Corp 7/4 King Fuels Announces Expansion Across the U.S.
GlobeNewswire 7/1 Phillips Edison & Company Announces Appointment of Devin Murphy to Board of Directors
GlobeNewswire 6/27 Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Inte...
GlobeNewswire 6/26 Almaden Announces Results of Annual General Meeting
GlobeNewswire 6/25 FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technolog...
GlobeNewswire 6/21 Lifetime Brands, Inc. Announces Results of 2024 Annual Meeting
GlobeNewswire 6/20 The International Food Information Council (IFIC) Releases Annual Food & Health Survey Revealing Ris...
GlobeNewswire 6/18 EyePoint Pharmaceuticals to Host R&D Day on June 26, 2024
GlobeNewswire 6/17 Phillips Edison & Company Inc. Invites You to Join Its Second Quarter 2024 Earnings Conference Call
GlobeNewswire 6/17 EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire 6/13 Rygen Technologies Launches Next-Gen Supply Chain Solution: AI-enabled TMS
GlobeNewswire 6/13 FibroBiologics Set to Join Russell 2000® Index
GlobeNewswire 6/12 Greystone Closes $22.9 Million in Total Debt Placement and Preferred Equity Financing for Fort Worth...
GlobeNewswire 6/6 FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
GlobeNewswire 6/5 EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire 5/30 Celebrate Life’s Sweet Surprises in New Children’s Book THE ICE CREAM TREE
GlobeNewswire 5/29 Phillips Edison & Company to Present at Nareit REITweek 2024 Investor Conference
GlobeNewswire 5/22 Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
GlobeNewswire 5/20 Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease We...
GlobeNewswire 5/16 Optimal Daily Dairy Consumption Remains Elusive Despite Well-Established Health Benefits
GlobeNewswire 5/16 First Wave BioPharma Changes Name to Entero Therapeutics
GlobeNewswire 5/16 EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire 5/15 FibroBiologics Announces 2024 Annual Meeting of Stockholders
Newsfile Corp 5/15 King Fuels Announces Strategic Expansion of Its Fuel Distribution Network in Texas, Colorado, Kansas...
GlobeNewswire 5/14 FibroBiologics Files 2024 First Quarter Report